What is Glutathione?
Glutathione (GSH) is a tripeptide your body makes from three amino acids: glutamate, cysteine, and glycine (L-γ-glutamyl-L-cysteinyl-glycine). It is the most important cellular antioxidant and is found in nearly every cell at concentrations of 1-10 mM [1]. An unusual γ-bond between the amino acids protects the molecule from being broken down prematurely by enzymes in the cell.
As the primary redox buffer, glutathione protects cells and tissues from oxidative stress caused by free radicals and reactive oxygen species (ROS). It neutralizes oxidants directly and serves as an essential cofactor for protective enzymes like glutathione peroxidase and glutathione S-transferase [2]. The ratio between the reduced form (GSH) and the oxidized form (GSSG) serves as a key indicator for the cell's current redox state.
Glutathione is a peptide active ingredient that is produced endogenously, but can also be taken as an oral dietary supplement or as an injectable preparation. Unlike peptide hormones such as GLP-1 receptor agonists, glutathione acts as a cellular protective peptide without a hormonal control function.
How is Glutathione Used?
Glutathione is primarily taken orally in doses of 250 to 1000 mg daily as a capsule, powder, or liposomal formulation. A randomized, placebo-controlled study in healthy adults shows that a daily dose of 250 mg or 1000 mg over 6 months significantly raises the body's own glutathione stores [3]. Due to enzymatic breakdown in the gastrointestinal tract, oral bioavailability is limited; liposomal formulations or precursors like N-acetylcysteine (NAC) are used to overcome this hurdle.
Injectable glutathione (intravenous or intramuscular) is mainly used in wellness clinics and, in some countries, as a prescription product. In Japan and the Philippines, there is official approval for specific liver diseases [4]. In the USA and the EU, there is no approval as a finished medicinal product, so use is off-label through compounding pharmacies [5]. Due to a lack of safety data and approval, the Philippine FDA explicitly warns against injections for skin lightening [6].
The following table compares the documented routes of administration for glutathione in terms of evidence and dosage:
| Route | Form | Evidence/Approval | Typical Dose (Studies/Practice) |
|---|---|---|---|
| Oral | Capsule, powder, liposomal | GRAS (FDA), RCT-proven [3] | 250-1000 mg/day |
| Intravenous | IV infusion or push | Off-label (US/EU); approved for liver therapy in JP/PH [4] | 600-1200 mg, 1-2x/week (unproven practice) |
| Intramuscular | IM injection | Off-label; no approval for skin lightening | 600 mg/week (unproven practice) |
| Topical | Cream, serum | OTC products available | Variable |
From Vial to Use: Injecting Glutathione
Injectable glutathione comes as a freeze-dried lyophilisate in a vial and is reconstituted with sterile water or isotonic sodium chloride solution before use. The resulting concentration depends on the ratio between the amount of powder and the volume of solvent. In compounding practice, the following typical guidelines are found:
- Vial size: 600 mg glutathione as lyophilisate
- Reconstitution with 6 ml sterile water yields 100 mg/ml
- For a desired amount of 600 mg: withdraw the entire 6 ml
- For 1200 mg (2 vials): 12 ml, typically as a slow IV infusion over 30-60 minutes
This calculation describes an unproven user practice from the wellness sector and does not provide any evidence of efficacy or safety. A standardized, clinically validated protocol for intravenous use for skin lightening or anti-aging does not exist [6]. For technical basics on mixing and storing peptide solutions, see the guides.
How Does Glutathione Work?
Glutathione works through its free thiol group (-SH) on the cysteine unit as the primary cellular redox buffer, scavenging reactive oxygen species and conjugating harmful electrophiles [2]. The biological protective functions cover five central areas of action:
- Antioxidant: Neutralizes free radicals, hydrogen peroxide, and lipid peroxides (as a cofactor for glutathione peroxidase)
- Detoxification: Binds toxins and drug metabolites via glutathione S-transferases, making them excretable
- Mitochondrial protection: Protects the mitochondria - the cell's powerhouses - from oxidative damage that would otherwise lead to energy loss and cell death
- Immune function: Supports the function of T-lymphocytes and phagocytes; a glutathione deficiency weakens the immune defense
- Melanin synthesis: Inhibits tyrosinase, the key enzyme in melanin production - this is the mechanism behind the skin-lightening effect [7]
The intracellular γ-glutamyl cycle ensures the continuous recycling of the molecule: the enzyme glutathione reductase converts oxidized GSSG back into active, reduced GSH using NADPH. This cycle ensures a high antioxidant capacity with a constant amount of peptide.
Glutathione and Skin Lightening - What Does the Evidence Say?
The evidence for glutathione for skin lightening shows moderate but qualitatively limited effects with oral and topical use, while controlled clinical data for intravenous injections are completely lacking. Interest in injectable glutathione is primarily driven by this cosmetic goal.
A systematic review from 2025 documents moderate lightening effects from oral and topical formulations, but rates the quality of evidence as low and points to a lack of long-term safety data [7]. Earlier reviews also concluded that methodological limitations, small sample sizes, and short study durations limit the conclusiveness of existing data [8].
For intravenous glutathione for skin lightening, no published clinical studies exist; an editorial in the South African Medical Journal in 2016 emphasized the insufficient safety data [9]. The Philippine drug authority FDA officially warned in 2019 against intravenous injections for lightening purposes [6].
Glutathione and Aging - The GlyNAC Studies
The combined administration of the precursors glycine and N-acetylcysteine (GlyNAC) boosts the body's own glutathione synthesis and, in a 16-week randomized clinical trial in older adults, improved glutathione levels, mitochondrial function, inflammation markers, insulin resistance, and cognitive performance [10]. Glycine and cysteine are the limiting building blocks of the body's own synthesis. A previous pilot study achieved comparable results [11].
The study results indicate that age-related glutathione deficiencies can be addressed through precursors, although this area of research is still in its early stages.
What Risks and Side Effects Are There?
Oral glutathione has a favorable safety profile and has been classified by the US FDA as GRAS (Generally Recognized As Safe) for food additives [12]. In a 6-month study with 1000 mg/day, no serious adverse events occurred in healthy subjects [3].
For injectable glutathione, risks and side effects are less systematically documented:
- Local reactions at the injection site (redness, pain, bruising)
- Allergic reactions, including anaphylaxis (rare)
- With high-dose IV use: gastrointestinal discomfort, temporary blood pressure changes
- Long-term risks of high-dose IV use are unknown [9]
- Special warning: contamination from non-pharmacy production can lead to serious infections - the FDA has documented such incidents [5]
When purchasing peptide preparations, purity and verified origin are crucial factors. The Vendor Radar helps with independent provider checks to avoid contaminated or adulterated batches.
What Is Still Unknown?
- There are no long-term studies (over 1 year) on oral high-dose supplementation
- The optimal dose and formulation (reduced vs. liposomal vs. S-acetyl) is not established
- Controlled clinical studies for IV use for skin lightening are completely lacking [9]
- The clinical relevance of skin-lightening effects compared to established depigmenting agents is unclear
- Whether glutathione supplementation provides clinical benefit in healthy people with normal levels is not proven
Glutathione at a Glance
| Property | Detail |
|---|---|
| Structure | Tripeptide (L-γ-glutamyl-L-cysteinyl-glycine), MW 307 g/mol |
| Primary Route | Oral (supplement); injectable off-label/clinical |
| Half-life | Very short (minutes range in plasma); stable intracellularly through recycling |
| Approval | Oral: GRAS (FDA); Injectable: approved in JP/PH for liver therapy; not FDA/EMA-approved as a finished drug |
| Evidence | Limited to moderate human data; RCTs for oral; no controlled studies for IV skin lightening |
Glutathione acts as a fundamental protective peptide in every cell of the body. For more information on related peptides and active ingredients, see the Peptide Library, including cellular protective peptides like SS-31 with a mitochondrial target.
Evidence at a glance
Editorial, sourced from primary literature - not medical advice.
Related peptides
Sources
- Richie JP Jr et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr 2015. PMID 24791752
- Richie JP Jr et al. Randomized controlled trial of oral glutathione supplementation. doi:10.1007/s00394-014-0706-z
- Sarkar R et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol 2025. PMID 39444151
- Sonthalia S et al. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol 2016. PMID 27088927
- Davids LM et al. Intravenous glutathione for skin lightening: Inadequate safety data. S Afr Med J 2016. PMID 27499402
- Kumar P et al. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults - Randomized Clinical Trial. J Gerontol A 2023. PMID 35975308
- Kumar P et al. GlyNAC supplementation in older adults - pilot clinical trial. Clin Transl Med 2021. PMID 33783984
- FDA Philippines Advisory No. 2019-182: Unsafe Use of Glutathione as Skin Lightening Agent
- FDA GRAS Notice GRN 244: Glutathione
This peptide is not injected - a calculation in the injection calculator is not intended here.